Nektar Therapeutics (ITH0) Revenue

1 Followers

Nektar Therapeutics Revenue

Nektar Therapeutics had a revenue of 10.13M in the quarter ending Jun 30, 2026, with -6.72%. This bring the company's revenue in the last twelve months to 54.59M, Increased -1.88%. In the fiscal year ending Dec 31, 2025, Nektar Therapeutics had annual revenue of 55.23M with -43.89% growth.

Revenue (ttm)

54.59M

Revenue Growth

-32.25%

P/S Ratio

38.67

Revenue/Employee

€876,698

Employees

Market Cap

€2.14B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	55.23M	-43.20M	-43.89%
Dec 31, 2024	98.43M	8.30M	+9.22%
Dec 31, 2023	90.12M	-1.93M	-2.10%
Dec 31, 2022	92.06M	-9.85M	-9.67%
Dec 31, 2021	101.91M	-51.01M	-33.36%
Dec 31, 2020	152.91M	38.30M	+33.41%
Dec 31, 2019	114.62M	-1.08B	-90.40%
Dec 31, 2018	1.19B	885.61M	+287.81%
Dec 31, 2017	307.71M	―	―